Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14298 | 713 | 34.0 | 81% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | B2T | Address | 12 | 86% | 1% | 6 |
2 | BREAST DIS UNIT | Address | 8 | 45% | 2% | 14 |
3 | POSITRON EMISSION MAMMOGRAPHY | Author keyword | 5 | 29% | 2% | 15 |
4 | PRIMARY STAGING | Author keyword | 3 | 45% | 1% | 5 |
5 | BREAST NEOPLASMS RADIONUCLIDE IMAGING | Author keyword | 2 | 32% | 1% | 6 |
6 | BASELINE STAGING | Author keyword | 2 | 67% | 0% | 2 |
7 | EARLY RESPONSE ASSESSMENT | Author keyword | 2 | 67% | 0% | 2 |
8 | F 18 2 FLUORO 2 DEOXY D GLUCOSE POSITRON EMISSION TOMOGRAPHY | Author keyword | 2 | 67% | 0% | 2 |
9 | INITIAL STAGING | Author keyword | 2 | 25% | 1% | 6 |
10 | RADIAT ONCOL TREATMENT | Address | 1 | 38% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | F 18 2 DEOXY 2 FLUORO D GLUCOSE PET | 69 | 91% | 4% | 29 |
2 | SUSPECTED RECURRENCE | 10 | 58% | 2% | 11 |
3 | 2 DEOXY 2 FLUORO D GLUCOSE PET | 9 | 83% | 1% | 5 |
4 | FLUORINE 18 FDG PET | 7 | 27% | 3% | 23 |
5 | AXILLARY INVOLVEMENT | 4 | 75% | 0% | 3 |
6 | MONITORING PRIMARY CHEMOTHERAPY | 3 | 100% | 0% | 3 |
7 | PREOPERATIVE PET CT | 3 | 100% | 0% | 3 |
8 | 2 F 18 FLUORO 2 DEOXY D GLUCOSE | 3 | 14% | 3% | 19 |
9 | METABOLIC FLARE | 2 | 23% | 1% | 9 |
10 | AXILLA | 2 | 18% | 2% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Performance of FDG PET/CT in the Clinical Management of Breast Cancer | 2013 | 37 | 87 | 78% |
Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response | 2015 | 1 | 41 | 41% |
Is there a role for positron emission tomography in breast cancer staging? | 2008 | 65 | 63 | 84% |
Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer | 2012 | 16 | 29 | 83% |
Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis | 2012 | 32 | 29 | 48% |
Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis | 2011 | 37 | 50 | 60% |
A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence | 2010 | 33 | 48 | 65% |
A systematic review of FDG-PET in breast cancer | 2010 | 17 | 70 | 91% |
Comparison of (18)FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis | 2013 | 10 | 16 | 56% |
FDG-PET and beyond: Molecular breast cancer imaging | 2005 | 88 | 41 | 68% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | B2T | 12 | 86% | 0.8% | 6 |
2 | BREAST DIS UNIT | 8 | 45% | 2.0% | 14 |
3 | RADIAT ONCOL TREATMENT | 1 | 38% | 0.4% | 3 |
4 | DOCTORAL B2T | 1 | 100% | 0.3% | 2 |
5 | DOCTORAL BIOL BIOTECHNOL | 1 | 100% | 0.3% | 2 |
6 | UMR LATIM 1101 | 1 | 33% | 0.4% | 3 |
7 | RADIOTHER Y NUCL MED UNIT | 1 | 13% | 0.8% | 6 |
8 | AHMANSON BIOL IMAGING NUCL MED CLIN | 1 | 50% | 0.1% | 1 |
9 | CANC HOSP E | 1 | 50% | 0.1% | 1 |
10 | CIRUGIA ORIENTE | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000192051 | F 18 FLUORIDE//BONE SCINTIGRAPHY//BONE SCAN INDEX |
2 | 0.0000182911 | SUV//STANDARDIZED UPTAKE VALUE//LUNG NEOPLASMS EMISSION CT ECT |
3 | 0.0000162286 | ATSUCHI MEM RADIOL//HAMAMATSU MED IMAGING//PET ANGIOGRAPHY |
4 | 0.0000145195 | INFLAMMATORY BREAST CANCER//NEOADJUVANT CHEMOTHERAPY//LOCALLY ADVANCED BREAST CANCER |
5 | 0.0000122366 | GLUT 1//GLUCOSE TRANSPORTER 1//GLUT 1 EXPRESSION |
6 | 0.0000120877 | F 18 FLT//F 18FLT//FLT |
7 | 0.0000119054 | FLUOROESTRADIOL//F 18 FES PET//FES PET |
8 | 0.0000109887 | SURVIVORSHIP CARE PLANS//SURVIVORSHIP CARE PLAN//TREATMENT SUMMARIES |
9 | 0.0000104327 | SCINTIMAMMOGRAPHY//TC 99M MIBI//TC 99M TETROFOSMIN |
10 | 0.0000097265 | BREAST MRI//BREAST NEOPLASMS MR//MR MAMMOGRAPHY |